Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis

Blood Adv (2017) 1 (17): 1312–1323.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals